PKAPX
Price
$14.52
Change
+$0.11 (+0.76%)
Updated
Sep 4 closing price
Net Assets
1.39B
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

PKAPX vs VVIAX

Header iconPKAPX vs VVIAX Comparison
Open Charts PKAPX vs VVIAXBanner chart's image
PIMCO RAE US I-2
Price$14.52
Change+$0.11 (+0.76%)
VolumeN/A
Net Assets1.39B
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
PKAPX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PKAPX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PKAPX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. PKAPX (1.4B). VVIAX pays higher dividends than PKAPX: VVIAX (2.10) vs PKAPX (1.52). PKAPX was incepted earlier than VVIAX: PKAPX (10 years) vs VVIAX (25 years). PKAPX (0.51) is less costly to investors than VVIAX (0.05). PKAPX is a more actively managed with annual turnover of: 73.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than PKAPX: VVIAX (3000) vs PKAPX (1000000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. PKAPX (3.89). VVIAX return over 5 years is better than : 70.16 vs. PKAPX (53.19).
PKAPXVVIAXPKAPX / VVIAX
Total Expense Ratio0.500.051,000%
Annual Report Gross Expense Ratio0.510.051,020%
Fund Existence10 years25 years-
Gain YTD11.8197.850151%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.4B203B1%
Annual Yield % from dividends1.522.1072%
Returns for 1 year3.897.7450%
Returns for 3 years26.7636.6173%
Returns for 5 years53.1970.1676%
Returns for 10 years87.65131.6167%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGS11.340.60
+5.59%
Aligos Therapeutics Inc
AEG7.52-0.03
-0.40%
Aegon Ltd
LFST5.37-0.10
-1.83%
LifeStance Health Group
TATT33.82-0.81
-2.34%
TAT Technologies Ltd
CNET1.51-0.06
-3.81%
ZW Data Action Technologies Inc